LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 107

Search options

  1. Book ; Thesis: Prüfung der klinischen Anwendbarkeit des Parametric Gammascope zur Erfassung der ungetriggerten Blutvolumenanalyse in Herz, Lunge und Leber am Patientenkollektiv

    Stoffels, Gabriele

    1996  

    Author's details vorgelegt von Gabriele Stoffels
    Language German
    Size 62 S. : Ill., graph. Darst.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Düsseldorf, Univ., Diss., 1996
    HBZ-ID HT008408958
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article ; Online: Diagnostic Accuracy of MR Spectroscopic Imaging and

    Mauler, Jörg / Lohmann, Philipp / Maudsley, Andrew A / Sheriff, Sulaiman / Hoevels, Moritz / Meissner, Anna-Katharina / Hamisch, Christina / Brunn, Anna / Deckert, Martina / Filss, Christian P / Stoffels, Gabriele / Dammers, Jürgen / Ruge, Maximillian I / Galldiks, Norbert / Mottaghy, Felix M / Langen, Karl-Josef / Shah, N Jon

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2024  Volume 65, Issue 1, Page(s) 16–21

    Abstract: Contrast-enhanced MRI is the method of choice for brain tumor diagnostics, despite its low specificity for tumor tissue. This study compared the contribution of MR spectroscopic imaging (MRSI) and amino acid PET to improve the detection of tumor tissue. ...

    Abstract Contrast-enhanced MRI is the method of choice for brain tumor diagnostics, despite its low specificity for tumor tissue. This study compared the contribution of MR spectroscopic imaging (MRSI) and amino acid PET to improve the detection of tumor tissue.
    MeSH term(s) Humans ; Magnetic Resonance Imaging/methods ; Glioma/diagnostic imaging ; Glioma/metabolism ; Magnetic Resonance Spectroscopy ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/pathology ; Positron-Emission Tomography/methods ; Tyrosine ; Biopsy
    Chemical Substances Tyrosine (42HK56048U)
    Language English
    Publishing date 2024-01-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.123.265868
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Structural connectome-based predictive modeling of cognitive deficits in treated glioma patients.

    Friedrich, Michel / Filss, Christian P / Lohmann, Philipp / Mottaghy, Felix M / Stoffels, Gabriele / Weiss Lucas, Carolin / Ruge, Maximilian I / Shah, N Jon / Caspers, Svenja / Langen, Karl-Josef / Fink, Gereon R / Galldiks, Norbert / Kocher, Martin

    Neuro-oncology advances

    2023  Volume 6, Issue 1, Page(s) vdad151

    Abstract: Background: In glioma patients, tumor growth and subsequent treatments are associated with various types of brain lesions. We hypothesized that cognitive functioning in these patients critically depends on the maintained structural connectivity of ... ...

    Abstract Background: In glioma patients, tumor growth and subsequent treatments are associated with various types of brain lesions. We hypothesized that cognitive functioning in these patients critically depends on the maintained structural connectivity of multiple brain networks.
    Methods: The study included 121 glioma patients (median age, 52 years; median Eastern Cooperative Oncology Group performance score 1; CNS-WHO Grade 3 or 4) after multimodal therapy. Cognitive performance was assessed by 10 tests in 5 cognitive domains at a median of 14 months after treatment initiation. Hybrid amino acid PET/MRI using the tracer O-(2-[
    Results: Compared to healthy controls (
    Conclusions: These results suggest that the cognitive performance of pretreated glioma patients is strongly related to structural connectivity between multiple brain networks and depends on the integrity of known network hubs also involved in other neurological disorders.
    Language English
    Publishing date 2023-11-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 3009682-0
    ISSN 2632-2498 ; 2632-2498
    ISSN (online) 2632-2498
    ISSN 2632-2498
    DOI 10.1093/noajnl/vdad151
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives.

    Langen, Karl-Josef / Galldiks, Norbert / Mauler, Jörg / Kocher, Martin / Filß, Christian Peter / Stoffels, Gabriele / Régio Brambilla, Cláudia / Stegmayr, Carina / Willuweit, Antje / Worthoff, Wieland Alexander / Shah, Nadim Jon / Lerche, Christoph / Mottaghy, Felix Manuel / Lohmann, Philipp

    Cancers

    2023  Volume 15, Issue 14

    Abstract: Advanced MRI methods and PET using radiolabelled amino acids provide valuable information, in addition to conventional MR imaging, for brain tumour diagnostics. These methods are particularly helpful in challenging situations such as the differentiation ... ...

    Abstract Advanced MRI methods and PET using radiolabelled amino acids provide valuable information, in addition to conventional MR imaging, for brain tumour diagnostics. These methods are particularly helpful in challenging situations such as the differentiation of malignant processes from benign lesions, the identification of non-enhancing glioma subregions, the differentiation of tumour progression from treatment-related changes, and the early assessment of responses to anticancer therapy. The debate over which of the methods is preferable in which situation is ongoing, and has been addressed in numerous studies. Currently, most radiology and nuclear medicine departments perform these examinations independently of each other, leading to multiple examinations for the patient. The advent of hybrid PET/MRI allowed a convergence of the methods, but to date simultaneous imaging has reached little relevance in clinical neuro-oncology. This is partly due to the limited availability of hybrid PET/MRI scanners, but is also due to the fact that PET is a second-line examination in brain tumours. PET is only required in equivocal situations, and the spatial co-registration of PET examinations of the brain to previous MRI is possible without disadvantage. A key factor for the benefit of PET/MRI in neuro-oncology is a multimodal approach that provides decisive improvements in the diagnostics of brain tumours compared with a single modality. This review focuses on studies investigating the diagnostic value of combined amino acid PET and 'advanced' MRI in patients with cerebral gliomas. Available studies suggest that the combination of amino acid PET and advanced MRI improves grading and the histomolecular characterisation of newly diagnosed tumours. Few data are available concerning the delineation of tumour extent. A clear additive diagnostic value of amino acid PET and advanced MRI can be achieved regarding the differentiation of tumour recurrence from treatment-related changes. Here, the PET-guided evaluation of advanced MR methods seems to be helpful. In summary, there is growing evidence that a multimodal approach can achieve decisive improvements in the diagnostics of cerebral gliomas, for which hybrid PET/MRI offers optimal conditions.
    Language English
    Publishing date 2023-07-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15143577
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis.

    Heinzel, Alexander / Mottaghy, Felix M / Filss, Christian / Stoffels, Gabriele / Lohmann, Philipp / Friedrich, Michel / Shah, Nadim J / Caspers, Svenja / Lucas, Carolin Weiss / Ruge, Maximilian I / Galldiks, Norbert / Fink, Gereon R / Langen, Karl-Josef / Kocher, Martin

    Journal of neuro-oncology

    2023  Volume 161, Issue 3, Page(s) 643–654

    Abstract: Purpose: In glioma patients, tumor development and multimodality therapy are associated with changes in health-related quality of life (HRQoL). It is largely unknown how different types and locations of tumor- and treatment-related brain lesions, as ... ...

    Abstract Purpose: In glioma patients, tumor development and multimodality therapy are associated with changes in health-related quality of life (HRQoL). It is largely unknown how different types and locations of tumor- and treatment-related brain lesions, as well as their relationship to white matter tracts and functional brain networks, affect HRQoL.
    Methods: In 121 patients with pretreated gliomas of WHO CNS grades 3 or 4, structural MRI, O-(2-[
    Results: Right hemisphere gliomas were associated with significantly less favorable outcomes in physical, role, emotional and social functioning, compared with left-sided tumors. Most functional HRQoL scores correlated significantly with right-sided white-matter tracts involvement by T2/FLAIR hyperintensities and with loss of within-network functional connectivity of right-sided nodes. Tumors of the left hemisphere caused significantly more communication deficits.
    Conclusion: In pretreated high-grade gliomas, right hemisphere lesions are associated with reduced HRQoL scores in most functional domains except communication ability, compared to tumors of the left hemisphere. These relationships are mainly observed for T2/FLAIR lesions involving structural and functional networks in the right hemisphere. The data suggest that sparing the right hemisphere from treatment-related tissue damage may improve HRQoL in glioma patients.
    MeSH term(s) Humans ; Brain Neoplasms/pathology ; Magnetic Resonance Imaging ; Quality of Life ; Positron-Emission Tomography ; Glioma/pathology ; Brain/pathology ; World Health Organization
    Language English
    Publishing date 2023-02-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-023-04254-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Assessment of Brain Tumour Perfusion Using Early-Phase

    Filss, Christian P / Cramer, Julian / Löher, Saskia / Lohmann, Philipp / Stoffels, Gabriele / Stegmayr, Carina / Kocher, Martin / Heinzel, Alexander / Galldiks, Norbert / Wittsack, Hans J / Sabel, Michael / Neumaier, Bernd / Scheins, Jürgen / Shah, N Jon / Meyer, Philipp T / Mottaghy, Felix M / Langen, Karl-Josef

    Molecular imaging and biology

    2023  Volume 26, Issue 1, Page(s) 36–44

    Abstract: Purpose: Morphological imaging using MRI is essential for brain tumour diagnostics. Dynamic susceptibility contrast (DSC) perfusion-weighted MRI (PWI), as well as amino acid PET, may provide additional information in ambiguous cases. Since PWI is often ... ...

    Abstract Purpose: Morphological imaging using MRI is essential for brain tumour diagnostics. Dynamic susceptibility contrast (DSC) perfusion-weighted MRI (PWI), as well as amino acid PET, may provide additional information in ambiguous cases. Since PWI is often unavailable in patients referred for amino acid PET, we explored whether maps of relative cerebral blood volume (rCBV) in brain tumours can be extracted from the early phase of PET using O-(2-
    Procedure: Using a hybrid brain PET/MRI scanner, PWI and dynamic
    Results: TBRs calculated from MR-rCBV and
    Conclusion: Early
    MeSH term(s) Humans ; Brain Neoplasms/pathology ; Glioma/pathology ; Magnetic Resonance Imaging/methods ; Positron-Emission Tomography/methods ; Tyrosine ; Perfusion ; Meningeal Neoplasms
    Chemical Substances Tyrosine (42HK56048U)
    Language English
    Publishing date 2023-10-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2079160-4
    ISSN 1860-2002 ; 1536-1632
    ISSN (online) 1860-2002
    ISSN 1536-1632
    DOI 10.1007/s11307-023-01861-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients.

    Friedrich, Michel / Farrher, Ezequiel / Caspers, Svenja / Lohmann, Philipp / Lerche, Christoph / Stoffels, Gabriele / Filss, Christian P / Weiss Lucas, Carolin / Ruge, Maximilian I / Langen, Karl-Josef / Shah, Nadim J / Fink, Gereon R / Galldiks, Norbert / Kocher, Martin

    Frontiers in oncology

    2022  Volume 12, Page(s) 998069

    Abstract: Background: In glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of damage on ... ...

    Abstract Background: In glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of damage on the fiber architecture of the affected white matter.
    Patients and methods: This study included 121 pretreated patients (median age, 52 years; ECOG performance score, 0 in 48%, 1-2 in 51%) with histomolecularly characterized glioma (WHO grade IV glioblastoma, n=81; WHO grade III anaplastic astrocytoma, n=28; WHO grade III anaplastic oligodendroglioma, n=12), who had a resection, radiotherapy, alkylating chemotherapy, or combinations thereof. After a median follow-up time of 14 months (range, 1-214 months), anatomic MR and O-(2-[
    Results: Lesion types differed in both affected tissue volumes and relative fiber densities compared to control values (resection cavities: median volume 20.9 mL, fiber density 16% of controls; contrast-enhanced lesions: 7.9 mL, 43%; FET uptake areas: 30.3 mL, 49%; T2/FLAIR hyperintensities: 53.4 mL, 57%, p<0.001). In T2/FLAIR-hyperintense lesions caused by peritumoral edema due to recurrent glioma (n=27), relative fiber density was as low as in lesions associated with radiation-induced gliosis (n=13, 48% vs. 53%, p=0.17). In regions with pathologically increased FET uptake, local fiber density was inversely related (p=0.005) to the extent of uptake. Total fiber loss associated with contrast-enhanced lesions (p=0.006) and T2/FLAIR hyperintense lesions (p=0.013) had a significant impact on overall ECOG score.
    Conclusions: These results suggest that apart from resection cavities, reduction in local fiber density is greatest in contrast-enhancing recurrent tumors, but total fiber loss induced by edema or gliosis has an equal detrimental effect on the patients' performance status due to the larger volume affected.
    Language English
    Publishing date 2022-11-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.998069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Prediction of response to lomustine-based chemotherapy in glioma patients at recurrence using MRI and FET PET.

    Wollring, Michael M / Werner, Jan-Michael / Bauer, Elena K / Tscherpel, Caroline / Ceccon, Garry S / Lohmann, Philipp / Stoffels, Gabriele / Kabbasch, Christoph / Goldbrunner, Roland / Fink, Gereon R / Langen, Karl-Josef / Galldiks, Norbert

    Neuro-oncology

    2022  Volume 25, Issue 5, Page(s) 984–994

    Abstract: Background: We evaluated O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET and MRI for early response assessment in recurrent glioma patients treated with lomustine-based chemotherapy.: Methods: Thirty-six adult patients with WHO CNS grade 3 or 4 gliomas ( ... ...

    Abstract Background: We evaluated O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET and MRI for early response assessment in recurrent glioma patients treated with lomustine-based chemotherapy.
    Methods: Thirty-six adult patients with WHO CNS grade 3 or 4 gliomas (glioblastoma, 69%) at recurrence (median number of recurrences, 1; range, 1-3) were retrospectively identified. Besides MRI, serial FET PET scans were performed at baseline and early after chemotherapy initiation (not later than two cycles). Tumor-to-brain ratios (TBR), metabolic tumor volumes (MTV), the occurrence of new distant hotspots with a mean TBR >1.6 at follow-up, and the dynamic parameter time-to-peak were derived from all FET PET scans. PET parameter thresholds were defined using ROC analyses to predict PFS of ≥6 months and OS of ≥12 months. MRI response assessment was based on RANO criteria. The predictive values of FET PET parameters and RANO criteria were subsequently evaluated using univariate and multivariate survival estimates.
    Results: After treatment initiation, the median follow-up time was 11 months (range, 3-71 months). Relative changes of TBR, MTV, and RANO criteria predicted a significantly longer PFS (all P ≤ .002) and OS (all P ≤ .045). At follow-up, the occurrence of new distant hotspots (n ≥ 1) predicted a worse outcome, with significantly shorter PFS (P = .005) and OS (P < .001). Time-to-peak changes did not predict a significantly longer survival. Multivariate survival analyses revealed that new distant hotspots at follow-up FET PET were most potent in predicting non-response (P < .001; HR, 8.578).
    Conclusions: Data suggest that FET PET provides complementary information to RANO criteria for response evaluation of lomustine-based chemotherapy early after treatment initiation.
    MeSH term(s) Adult ; Humans ; Lomustine/therapeutic use ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/drug therapy ; Brain Neoplasms/metabolism ; Retrospective Studies ; Radiopharmaceuticals/metabolism ; Glioma/diagnostic imaging ; Glioma/drug therapy ; Glioma/metabolism ; Magnetic Resonance Imaging ; Positron-Emission Tomography ; Tyrosine/metabolism
    Chemical Substances Lomustine (7BRF0Z81KG) ; Radiopharmaceuticals ; Tyrosine (42HK56048U)
    Language English
    Publishing date 2022-10-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2028601-6
    ISSN 1523-5866 ; 1522-8517
    ISSN (online) 1523-5866
    ISSN 1522-8517
    DOI 10.1093/neuonc/noac229
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Surgery of Motor Eloquent Glioblastoma Guided by TMS-Informed Tractography: Driving Resection Completeness Towards Prolonged Survival.

    Weiss Lucas, Carolin / Faymonville, Andrea Maria / Loução, Ricardo / Schroeter, Catharina / Nettekoven, Charlotte / Oros-Peusquens, Ana-Maria / Langen, Karl Josef / Shah, N Jon / Stoffels, Gabriele / Neuschmelting, Volker / Blau, Tobias / Neuschmelting, Hannah / Hellmich, Martin / Kocher, Martin / Grefkes, Christian / Goldbrunner, Roland

    Frontiers in oncology

    2022  Volume 12, Page(s) 874631

    Abstract: Background: Surgical treatment of patients with glioblastoma affecting motor eloquent brain regions remains critically discussed given the risk-benefit dilemma of prolonging survival at the cost of motor-functional damage. Tractography informed by ... ...

    Abstract Background: Surgical treatment of patients with glioblastoma affecting motor eloquent brain regions remains critically discussed given the risk-benefit dilemma of prolonging survival at the cost of motor-functional damage. Tractography informed by navigated transcranial magnetic stimulation (nTMS-informed tractography, TIT) provides a rather robust estimate of the individual location of the corticospinal tract (CST), a highly vulnerable structure with poor functional reorganisation potential. We hypothesised that by a more comprehensive, individualised surgical decision-making using TIT, tumours in close relationship to the CST can be resected with at least equal probability of gross total resection (GTR) than less eloquently located tumours without causing significantly more gross motor function harm. Moreover, we explored whether the completeness of TIT-aided resection translates to longer survival.
    Methods: A total of 61 patients (median age 63 years, m = 34) with primary glioblastoma neighbouring or involving the CST were operated on between 2010 and 2015. TIT was performed to inform surgical planning in 35 of the patients (group T; vs. 26 control patients). To achieve largely unconfounded group comparisons for each co-primary outcome (i.e., gross-motor functional worsening, GTR, survival), (i) uni- and multivariate regression analyses were performed to identify features of optimal outcome prediction; (ii), optimal propensity score matching (PSM) was applied to balance those features pairwise across groups, followed by (iii) pairwise group comparison.
    Results: Patients in group T featured a significantly higher lesion-CST overlap compared to controls (8.7 ± 10.7% vs. 3.8 ± 5.7%; p = 0.022). The frequency of gross motor worsening was higher in group T, albeit non-significant (n = 5/35 vs. n = 0/26; p = 0.108). PSM-based paired-sample comparison, controlling for the confounders of preoperative tumour volume and vicinity to the delicate vasculature of the insula, showed higher GTR rates in group T (77% vs. 69%; p = 0.025), particularly in patients with
    Conclusion: The benefit of TIT-aided GTR appears to overcome the drawbacks of potentially elevated motor functional risk in motor eloquent tumour localisation, leading to prolonged survival of patients with primary glioblastoma close to the CST.
    Language English
    Publishing date 2022-05-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.874631
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cost Effectiveness of

    Rosen, Jurij / Ceccon, Garry / Bauer, Elena K / Werner, Jan-Michael / Tscherpel, Caroline / Dunkl, Veronika / Rapp, Marion / Sabel, Michael / Herrlinger, Ulrich / Heinzel, Alexander / Schäfer, Niklas / Ruge, Maximilian / Goldbrunner, Roland / Stoffels, Gabriele / Kabbasch, Christoph / Fink, Gereon R / Langen, Karl-Josef / Galldiks, Norbert

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2022  Volume 63, Issue 11, Page(s) 1677–1682

    Abstract: In light of increasing health-care costs, higher medical expenses should be justified socioeconomically. Therefore, we calculated the effectiveness and cost effectiveness of PET using the radiolabeled amino ... ...

    Abstract In light of increasing health-care costs, higher medical expenses should be justified socioeconomically. Therefore, we calculated the effectiveness and cost effectiveness of PET using the radiolabeled amino acid
    MeSH term(s) Humans ; Temozolomide/therapeutic use ; Cost-Benefit Analysis ; Brain Neoplasms/metabolism ; Radiopharmaceuticals/therapeutic use ; Glioma ; Positron-Emission Tomography/methods ; Magnetic Resonance Imaging/methods ; Tyrosine
    Chemical Substances Temozolomide (YF1K15M17Y) ; Radiopharmaceuticals ; Tyrosine (42HK56048U)
    Language English
    Publishing date 2022-04-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.122.263790
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top